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CME: COPD in South Africa – 
under-recognised and undertreated
Chronic obstructive pulmonary disease (COPD) is frequently a 
challenge for both patient and doctor. Even the name causes much 
head scratching for many sufferers. ‘Asthma I know’, and ‘emphysema 
I have heard of ’, but COPD – a complex syndrome extending from 
chronic bronchitis to emphysema – is not well understood or 
easily explained. This is in part the fault of pulmonologists, but as 
knowledge grows, there are increasing attempts to split COPD into 
more clinically relevant phenotypes. This will hopefully allow for 
clearer understanding and better treatment choices. With COPD, 
much can still be done despite its being incurable and lung function 
impairment being irreversible. 
COPD is a common, preventable but incurable disease currently 
ranked third in global mortality. Worldwide 65 million people are 
estimated to have moderate to severe disease, and COPD accounts 
for 3 million deaths annually, of which 90% are said to occur in low- 
and middle-income countries. Yet despite these staggering numbers, 
COPD remains both under-recognised and undertreated in most 
populations, including our own. There are many reasons for this, not 
least clinicians’ often fatalistic attitude with regard to its treatment. 
This CME highlights key aspects of the diagnosis and 
pharmacological and non-pharmacological treatment, as well as 
new developments in management of severe COPD. We also include 
articles highlighting non-smoking-related COPD and some tips for 
accurate spirometry. 
Improving pulmonary function in 
emphysema and asthma
This issue of SAMJ carries a Forum article[1] on endoscopic lung 
volume reduction to improve pulmonary function in severe 
emphysema that is a distillation of recommendations for its use, 
based on published evidence, international expert opinion, local 
expertise and local commercial access to devices, that will be 
published in full in the October issue.[2]
In addition, we publish recommendations for the use of 
bronchial thermoplasty in the management of severe asthma.[3] It is 
recommended that all endoscopic bronchothermoplasty procedures 
for severe asthma should be performed in the context of a local and/or 
international registry. The Assembly on Interventional Pulmonology 
of the South African Thoracic Society is willing to assist potential 
centres wishing to establish a thermoplasty and endoscopic lung 
volume reduction service in terms of training and accreditation.
Nine-month infant HIV testing
In South Africa (SA) excellent gains have been made in prevention 
of mother-to-child transmission (PMTCT) since 2002, with over 
90% of HIV-infected women accessing PMTCT. The national early 
transmission rate of HIV infection as measured at around 6 weeks 
of age is on track to meet the National Strategic Plan target of <2% 
in 2015. 
To detect postnatal transmission of HIV (via maternal 
infections not diagnosed during pregnancy, infection acquired 
late in pregnancy or during breastfeeding, poor adherence to ART 
during breastfeeding, and mixed infant feeding practices), national 
guidelines recommend that HIV-exposed uninfected (HEU) infants 
undergo repeat HIV testing 6 weeks after weaning and at 18 months 
of age. But HIV testing after weaning and at 18 months is poorly 
implemented and monitored. Consequently the rate of postnatal 
transmission and the extent of the paediatric HIV epidemic in SA 
remain unmeasured, and HIV-infected infants and children remain 
unidentified. 
In an article suggesting that it is time to implement 9-month infant 
HIV testing in SA, Fairlie et al.[4] explore a model that posits the 
adoption in SA of World Health Organization (WHO) guidelines, 
available since 2008, that recommend infant HIV diagnosis using 
an antibody detection assay at 9 months of age for all HEU infants 
and a confirmatory HIV polymerase chain reaction test if the HRT 
is positive. If SA were to adopt the WHO recommendation to test 
all HEU infants at the 9-month measles vaccine visit (Expanded 
Programme on Immunization), when measles (MCV1) coverage 
rates in SA are reported at 95%, more HIV-infected infants would 
be identified earlier and benefit from early initiation of combination 
antiretroviral therapy, while HIV infection would be excluded in 80 - 
100% of HEU infants.
With dwindling early vertical transmission rates as a result of 
SA’s successful PMTCT programme, proportionately more infants 
and children diagnosed after 6 weeks of age will contribute to the 
paediatric HIV epidemic, and it is clearly important that they be 
identified.
Codeine misuse and dependence in SA
Misuse of prescription and over-the-counter codeine-containing 
products is a global public health issue. SA is considering introducing 
regulations to reduce the amount of codeine in a tablet to 10 mg and 
to up-schedule norcodeine and acetylcodeine. Dada et al.[5] analysed 
substance abuse treatment admissions to investigate the extent 
of treatment demand related to the misuse of codeine or codeine 
dependence in SA and the profile of patients seeking treatment for 
their misuse or dependency on codeine (as part of a comprehensive, 
multicountry Codeine Misuse and Dependence (Codemisused) 
Study funded by the European Union). Fewer than 1% of persons 
had codeine as their primary substance of abuse, similar to findings 
reported from centres in the UK and Ireland. These percentages are 
low compared with alcohol, cannabis, methamphetamine and other 
substances of abuse in SA, but translate to over 400 persons per year 
needing treatment for their codeine misuse in specialist substance 
abuse treatment centres.
Recommendations for the 
anticoagulation of pregnant patients 
with mechanical heart valves
The above recommendations[6] are key reading for anyone 
in volved in the management of pregnant women with mechanical 
heart valves. The Southern African Society of Thrombosis and 
Haemostasis reviewed available literature and comprehensive 
evidence-based guidelines for the anticoagulation of these patients. 
These SA recommendations discuss the use of enoxaparin (Clexane), 
unfractionated heparin and warfarin. (The recommendation to 
only use enoxaparin is based on the fact that adequate laboratory 
monitoring is available in SA for enoxaparin and not other low-
molecular-weight heparins (LMWHs) – the testing of LMWH is not 
interchangeable.) The choice of anticoagulant remains challenging 
because both vitamin K antagonists and heparins may be associated 
with maternal and fetal adverse events and should be considered 
in conjunction with risk factors for thromboembolism (valve type, 
position and history of thromboembolism), economic factors 
(availability and cost of the anticoagulants, access to laboratory 
testing and specialist care) and maternal preferences.
For colleagues wishing to understand the mechanisms of 
action and pharmacology of antithrombotic agents, I recommend 
‘Pharmacology of antithrombotic drugs: An assessment of oral 
antiplatelet and anticoagulant treatments’, published in a recent issue 
of The Lancet.[7]
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Ebola: Lessons learned
The dangerous, debilitating and deadly Western African Ebola 
outbreak, which caused >10 000 deaths in some 430 days, has 
been magnificently brought under control thanks to Médicins 
sans Frontières, followed by many dedicated health personnel 
(some of them South African) and deployment by several 
countries of their military personnel possessing key logistics 
capability. Also, there was superb shared intergovernmental 
decision-making (on the part of the governments of the 
countries directly involved and those threatened as neighbours) 
in spite of an initial crippling of any response by the decisions 
of the airlines. As expressed by Bruce Aylward, Assistant 
Director-General of the WHO Polio and Emergencies cluster,[8] 
success in controlling the epidemic required turning the 
traditional public health strategies of support and education 
of affected communities, contact tracing and isolation to stop 
transmission, treatment of victims and safe burial of those who 
did die, on its head – rapid establishment of treatment centres, 
with rapid training of burial teams (led by the Red Cross) first, 
followed by contact tracing, and creation of a UN air-bridge to 
ensure humanitarian aid to affected communities.
There can be no complacency, as Ebola does smoulder on 
in Sierra Leone, while new cases have recently occurred in 
Liberia and are likely to occur in the future … see ‘Ebola: 
Lessons learned’.[9]
Viral haemorrhagic fever (VHF)  
in South Africa
In a ‘Forum’ article on nososcomial transmission of 
VHF in South Africa,[10] Guy Richards describes several 
cases of haemorrhagic fever and the measures required to 
prevent nosocomial transmission. In SA the only endemic 
haemorrhagic fever is Crimean-Congo haemorrhagic fever, 
transmitted by the Hyalomma tick, which is ubiquitous in 
cattle farming areas. Johannesburg’s health centres have had to 
deal with all imported cases of VHF, whether from rural areas 
in SA or from countries to the north. 
The accompanying review by Richards et al.[11] on VHF in 
South Africa is mandatory reading.
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